Compound restores dopamine activity in a rat perimenopause model
In model rats, recordings averaged 1.201 active dopamine-producing cells per electrode path after the compound, versus 1.938 after an injection without it.

Our read
Interventions- Studied:
- Experiments in 7 VCD-treated rats, against vehicle
- What changed:
- Dopamine neuron population activity was 1.201 ± 0.143 cells per track against 1.938 ± 0.148 cells per track with vehicle
- The catch:
- Only 7 rats per group in the electrophysiology recordings
Editor of record: Boris Djordjevic · AgingResearch.News
In an experiment in female Sprague Dawley rats around six months old, researchers tested MP-III-022 in a chemically induced model of perimenopause, the transition toward menopause. The model mimicked gradual loss of egg-containing structures in the ovaries and hormonal instability. The compound boosts receptors for a chemical that inhibits nerve cell activity.
Rats received a single injection of 10 milligrams per kilogram, or an injection without the compound, 20 minutes before brain recordings under anesthesia. Model rats had more spontaneously active dopamine-producing nerve cells along each recording electrode path than naturally cycling controls. MP-III-022 returned this measure to control levels. The reported comparisons included seven rats per group. The compound did not significantly change this measure in naturally cycling rats.
Why it matters
Psychiatric instability during the transition to menopause raises questions about alternatives to standard antipsychotics. The authors propose this receptor-targeting approach as one such alternative.
Caveats
The outcome was electrical activity in anesthetized rats, not psychiatric symptoms. This acute experiment did not establish symptom relief or improved tolerability in women.
The paper
The University of Texas at San Antonio Health Science Center
Psychopharmacology, Sep 23, 2026, Open access


Comments
Be the first to comment.